Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of Analyst/ Institutional Investor Meetings with the Company to be held on 25th and 26th November 2021. The schedule of the meetings is subject to change and the change may occur due to exigencies on the part of Investor/ Analyst/ Company.
The above information is a part of company’s filings submitted to BSE.
